TGFB1 and hepatocellular carcinoma: This suggests IL-15 ‘armoring’ counteracts the exhaustion program typically induced by the hepatocellular carcinoma microenvironment, a hypothesis further supported by the observation that non-responders exhibited higher baseline serum levels of TGF-β and adenosine, known suppressors of IL-15 signaling.